GMED Stock: Price, Earnings History and SEC Filings
Globus Medical, Inc. (GMED) last traded at $78.05, down 5.86% on the latest session and up 4.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.34 against an analyst estimate of $1.12, a beat of 19.6%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GMED earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $1.34 | $1.12 | +19.64% |
| Mar 2026 | May 7, 2026 | $1.12 | $0.92 | +21.74% |
| Dec 2025 | Feb 24, 2026 | $1.28 | $1.06 | +20.75% |
| Sep 2025 | Nov 6, 2025 | $1.18 | $0.79 | +49.37% |
GMED beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
How GMED reacts to earnings
Across its last 8 earnings releases, GMED moved 11.8% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | +1.57% |
| 2026-05-07 | After close | -8.37% |
| 2026-02-24 | After close | +4.72% |
| 2026-01-07 | After close | +4.51% |
| 2025-11-06 | After close | +35.94% |
| 2025-08-07 | After close | +8.47% |
| 2025-07-21 | Before open | -7.90% |
| 2025-05-08 | After close | -22.96% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
GMED financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.9B | $538M | $589M | 18.3% | $3.92 |
| 2024 | $2.5B | $103M | $405M | 4.1% | $0.75 |
| 2023 | $1.6B | $123M | $165M | 7.8% | $1.07 |
| 2022 | $1.0B | $190M | $104M | 18.6% | $1.85 |
| 2021 | $958M | $149M | $219M | 15.6% | $1.44 |
| 2020 | $789M | $102M | $135M | 13.0% | $1.01 |
| 2019 | $785M | $155M | $101M | 19.8% | $1.52 |
| 2018 | $713M | $156M | $122M | 21.9% | $1.54 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for GMED
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 4, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 10-Q · May 7, 2026
- 8-K · May 7, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 24, 2026
- 8-K · Mar 23, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 10-K · Feb 24, 2026
- 8-K · Feb 24, 2026Results of operations, Financial statements and exhibits
- 8-K · Jan 7, 2026Results of operations, Financial statements and exhibits
Insider filing activity
GMED insiders filed 2 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
GMED news
- Is Globus Medical (GMED) Undervalued On Its Earnings Beat And Share Price Pullback?Oct 31, 2026 · finance.yahoo.com
- Globus Medical Stock Gains Attention After Earnings Beat And Continued GrowthOct 31, 2026 · finance.yahoo.com
- SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook CutOct 30, 2026 · finance.yahoo.com
- Alphatec Sinks 36% on Guidance Cut as Q3 Revenue Falls ShortOct 30, 2026 · tikr.com
- DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins RiseOct 30, 2026 · finance.yahoo.com
- DaVita Q3 Earnings Beat Estimates on IKC Strength, Revenues Rise Y/YOct 30, 2026 · finance.yahoo.com
- 2 cash-producing stocks with promising prospects and 1 we avoidOct 30, 2026 · finance.yahoo.com
- Reasons to Hold Hinge Health Stock in Your Portfolio for NowOct 29, 2026 · finance.yahoo.com
About Globus Medical, Inc.
Globus Medical, Inc. (GMED) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.